INTRODUCTION
============

Periodontitis is defined as a chronic multi-factorial inflammatory disease associated with dysbiotic plaque biofilms and characterized by progressive destruction of the tooth-supporting apparatus. Its primary features include the loss of periodontal tissue support, manifested through clinical attachment level (CAL) loss, radiographically assessed alveolar bone loss, the presence of periodontal pocket and gingival bleeding \[[@B1]\].

The progression of periodontal disease is relevant for understanding its etiopathogenesis and clinical manifestations. Longitudinal studies have revealed that in the absence of treatment, disease progression is a relatively rare event that occurs through increased pocket depth in a small number of subjects, primarily at interproximal sites of molar teeth, while mid-buccal sites experience a higher incidence of recession \[[@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9]\].

The definition of disease progression has varied in the available literature, from a CAL loss of ≥2 mm \[[@B10][@B11]\] to a loss of ≥3 mm \[[@B12]\]. Most information available on disease progression is based on longitudinal studies that have evaluated patients that did not undergo periodontal therapy and were followed for different periods of time \[[@B9][@B13]\]. Recent longitudinal studies that have followed healthy and untreated diseased subjects have provided relevant insights into the disease mechanisms of periodontitis. Teles and colleagues \[[@B14]\] followed 113 periodontally healthy patients and 302 periodontitis patients for 12 months and concluded that only a small number of the evaluated sites (0.7%) were classified as progressing and that many more shallow sites progressed than did deeper sites (387 vs. 15). Moreover, in an analysis of the differences in disease progression between healthy and diseased subjects, 51.4% of the sites that were considered to be active belonged to the patients diagnosed with severe disease, 33.4% to those who were diagnosed with moderate disease, and 15.2% to healthy patients, indicating that progression mainly occurred at shallow sites in diseased patients. This observation suggested that clinicians should focus on the entire disease process that affects the patient, rather than only on the deep sites \[[@B14]\].

Similar findings were reported in a recent systematic review finding that the mean annual CAL change was highly variable, with a mean annual CAL loss of 0.1 mm. Interestingly, only geographic location or ethnic status (a proxy for socioeconomic status) showed evidence of a statistically significant effect on mean attachment change \[[@B15]\].

Although this information is certainly pertinent for the understanding of periodontal disease, and also necessary to establish new avenues of treatment and diagnostic tools, it may not necessarily apply to patients who have already undergone therapy.

The goals of periodontal therapy are arresting disease progression, reducing the risk of tooth loss, restoring tissues that have been lost as a result of disease, and finally, preventing its recurrence \[[@B16]\]. Surgical and non-surgical treatments of periodontitis have achieved positive clinical outcomes, as described in published systematic reviews \[[@B17][@B18][@B19][@B20]\]. Similarly, supportive periodontal therapy (SPT) has been shown to be effective in maintaining periodontal health and preventing tooth loss in patients with periodontitis \[[@B21][@B22][@B23][@B24]\].

In spite of this high predictability, several patient- and tooth-related factors have been associated with tooth loss during SPT, such as age, smoking, and the presence of furcations \[[@B25]\]. However, information on other predictors of disease progression in subjects who have received periodontal therapy and are under SPT is rather scarce, and there is limited evidence on systemic or local factors that may contribute to CAL loss \[[@B26]\].

The purpose of this review was therefore: 1) to systematically assess the available evidence on periodontal disease progression, defined as CAL loss, in patients who have been treated for periodontitis and are under SPT; and 2) to further identify predictors of CAL loss among these patients.

PROTOCOL DEVELOPMENT AND FOCUSED QUESTION
=========================================

The study protocol was designed prior to the start of the review according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement \[[@B27]\]. The protocol aimed at answering the following focused question: In adult patients treated for periodontitis (population), what is the disease progression in terms of CAL loss (primary outcome) after surgical or non-surgical treatment?

Eligibility criteria
--------------------

1.  • Population: patients older than 18 diagnosed and treated for periodontitis under SPT.

2.  • Intervention: surgical or non-surgical periodontal therapy.

3.  • Comparison: surgical versus non-surgical therapy, different modalities of surgical and non-surgical therapy in controlled studies.

4.  • Outcome: disease progression (defined as CAL loss).

5.  • Study design: randomized controlled trials (RCTs), prospective cohort studies and prospective case series with a minimum of 10 patients (5 per group in controlled studies).

Exclusion criteria
------------------

1.  • Review or preclinical studies

2.  • Studies with less than 5 years of follow-up

3.  • Retrospective studies

4.  • Studies aiming at regenerating the periodontum

5.  • Studies with unspecified or unstandardized treatments

6.  • Studies reporting on specific populations, such as patients with diabetes

7.  • Studies reporting on early-onset periodontitis or refractory periodontitis

Types of interventions and comparisons
--------------------------------------

The present review considered any surgical or non-surgical interventions and any possible comparisons among them.

Type of outcomes
----------------

The primary outcome was CAL change. The following secondary outcomes were studied:

1.  • Radiographic bone loss measured on peri-apical radiographs

2.  • Tooth loss

3.  • Age, demographics, socioeconomic status, and lifestyle

INFORMATION SOURCES AND SEARCH
==============================

Electronic search
-----------------

Three electronic databases were used as sources in the search for publications: 1) The National Library of Medicine (MEDLINE via PubMed); 2) Embase; and 3) the Cochrane Central Register of Controlled Trials. These databases were searched for articles published through November 2018. The search was limited to human subjects.

Manual search
-------------

All reference lists of the selected publications were checked for cross-references. In addition, the following journals were hand-searched from the year 2005 to 2018: *Journal of Clinical Periodontology*, *Journal of Periodontology*, *Clinical Oral Implants Research*, *Journal of Periodontal Research*, and *Journal of Dental Research and Clinical Oral Investigations*.

Search strategy
---------------

Key words, MesH terms, and free terms were used to conduct the search while Boolean operators (OR, AND) were used to combine the searches. The search strategy was limited to human studies and the English language, and the search applied was the following:

1.  (scaling and root planing) OR (basic periodontal therapy) OR (non surgical periodontal therapy)

2.  (periodontal access flap surgery) OR (open flap debridement) OR (osseous resective surgery) OR (modified widman flap) OR (periodontal access surgery)

3.  (\#1) OR (\#2)

4.  (periodontal disease progression) OR (disease progression) \[mh\] OR (clinical attachment level) OR (periodontal attachment loss) \[mh\] OR (treatment outcomes) \[mh\] OR (longitudinal studies) \[mh\]

5.  (\#3) AND (\#4)

6.  (periodontal regeneration) OR (peri-implantitis) \[mh\]

7.  (\#5) NOT (\#6)

Screening methods
-----------------

Two reviewers (ISS and SWY) conducted the primary search by independently screening the titles and abstracts. The same reviewers selected the full manuscripts of investigations meeting the eligibility criteria, or those with insufficient data in the title and abstract to make a clear decision. Any disagreement was resolved by discussion with a third reviewer (JKC). The inter-reviewer reliability (percentage of agreement and kappa correlation coefficient) of the full-text analysis was calculated.

Data extraction
---------------

The same 2 reviewers performed duplicate data extraction. When data were incomplete or missing, authors of the publications were contacted for clarification. If agreement could not be reached, data were excluded until further clarification was available. When the results of a study were published more than once, only the longest follow-up was included, unless there were different outcomes of interest.

Quality assessment (risk of bias in individual publications)
------------------------------------------------------------

The quality of the included publications was assessed by 1 reviewer (SWY) following the recommendations of the Cochrane Collaboration \[[@B28]\]. The following items were evaluated to generate an overall assessment of low, high, or unclear risk of bias: selection bias (sequence generation and allocation concealment), performance bias (blinding of participants/personnel), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), selective reporting bias (selective reporting outcomes), and finally other potential sources of bias. Furthermore, the Newcastle-Ottawa Scale for cohort studies and a modification of the scale for cross-sectional studies were used to assess the risk of bias in individual observational studies \[[@B29]\].

Data analyses
-------------

Data were pooled into tables and the publications were grouped according to the type of studies and interventions. A descriptive summary was created to determine the quantity of the data and to analyze the characteristics and results of each publication. This enabled a confirmation of the similarities of the publications, the reported outcomes, the subgroups, and the predictors analyzed (site-, tooth-, or patient-related factors).

RESULTS
=======

Search and publication characteristics
--------------------------------------

[Figure 1](#F1){ref-type="fig"} presents a flow chart summarizing the results of the selection process. The electronic search provided a total of 1,931 titles/abstracts. Out of these, 1,894 were excluded (inter-reader agreement, 98.4%; κ=0.47; *P*\<0.001; 90% confidence interval \[CI\], 0.33--0.59). The resulting number of obtained full-text articles was 37. The hand search provided 20 additional publications, resulting in an overall number of 57 full-text articles. Out of these, 40 were excluded (inter-reader agreement, 91.2%; κ=0.80; *P*\<0.001; 90% CI, 0.62--0.95). Finally, 17 publications belonging to 14 investigations met the eligibility criteria and were included. The reasons for excluding studies after full-text review are detailed in [Supplementary Table 1](#S1){ref-type="supplementary-material"}. Briefly, the reasons were: no CAL values (n=13), a non-prospective design (n=6), follow-up \<5 years (n=7), inclusion of \<10 patients (n=2), unstandardized/unclear treatment (n=5), and irrelevance (n=7).

![Flow chart depicting the search strategy and study selection process.](jpis-49-60-g001){#F1}

Quality assessment of the included publications
-----------------------------------------------

Twelve of the included studies were RCTs. Five studies had a non-randomized design. In addition, 1 RCT provided follow-up data \[[@B30]\] and 2 RCTs were coupled with additional publications that provided further outcome data from the same follow-up period \[[@B31][@B32]\]. The full checklist from the Cochrane Collaboration tool for assessing the risk of bias was applied for RCTs. Among the 9 randomized studies with 12 publications, 2 publications were part II of the same follow-up and were not included in the table. One of the studies was considered to have a moderate risk of bias and the remaining studies were considered to have a high risk of bias ([Table 1](#T1){ref-type="table"}). The quality assessment of the non-randomized studies using the Newcastle-Ottawa Scale can be found in [Supplementary Table 2](#S2){ref-type="supplementary-material"}.

###### Risk of bias of randomized studies according to the Cochrane Collaboration recommendations (Higgins and Green, 2011)

![](jpis-49-60-i001)

  References                             Selection bias   Performance bias   Detection bias   Attrition bias   Selective reporting bias   Other potential risk of bias   
  -------------------------------------- ---------------- ------------------ ---------------- ---------------- -------------------------- ------------------------------ ------
  Crespi et al. (2011) \[[@B35]\]        High             High               High             High             High                       Low                            Low
  Gaspirc & Skaleric (2007) \[[@B57]\]   High             High               High             High             Low                        High                           Low
  Kaldahl et al. (1996) \[[@B43]\]       High             High               High             High             High                       High                           High
  Lindhe et al. (1984) \[[@B42]\]        High             High               High             High             High                       Low                            Low
  Pihlstrom et al. (1983) \[[@B32]\]     High             High               High             High             High                       Low                            High
  Preus et al. (2017) \[[@B36]\]         Low              Low                High             High             Low                        High                           Low
  Ramfjord et al. (1975) \[[@B56]\]      High             High               High             High             Low                        Low                            Low
  Knowles et al. (1979) \[[@B30]\]       High             High               High             High             Unclear                    High                           High
  Ramfjord et al. (1987) \[[@B41]\]      High             High               High             High             High                       Low                            Low
  Serino et al. (2001) \[[@B40]\]        High             High               High             High             High                       Low                            Low

Description of the included publications
----------------------------------------

A total of 964 patients were evaluated in the present systematic review, with the minimum number of subjects reported being 10 patients \[[@B32][@B33]\] and the maximum being 334 patients \[[@B34]\]. The follow-up ranged from 5 to 15 years \[[@B35]\], with 3 publications reporting data from more than 10 years of follow-up.

Interventions
-------------

[Table 2](#T2){ref-type="table"} depicts the methodological characteristics of the selected studies. Three publications reported interventions involving periodontal surgery, 3 reported non-surgical approaches, and 11 publications reported comparisons between surgical and non-surgical therapy. The most utilized periodontal surgical intervention was the modified Widman flap (MWF), which was reported in 14 publications, whereas 5 publications reported on different modalities of flap osseous surgery (FOS). Among the publications that evaluated non-surgical therapy, 12 publications utilized scaling and root planning (SRP), of which 2 publications utilized systemic antibiotics (metronidazole or tetracycline) as adjunctive therapy \[[@B36][@B37]\].

###### Methodological characteristics and outcomes measured by the included studies

![](jpis-49-60-i002)

  Authors (year)              Reference    Intervention            Design      FU (yr)   Patients   Test         Control   Other treatments      Outcomes
  --------------------------- ------------ ----------------------- ----------- --------- ---------- ------------ --------- --------------------- --------------------------------
  Axelsson & Lindhe (1981)    \[[@B38]\]   Surgery                 PCS         6         25                      MWF                             PI, GI, PD, CAL
  Crespi et al. (2011)        \[[@B35]\]   Surgery                 RCT split   15        25         FOS+CO2L     MWF                             PI, GI, PD, CAL
  Gaspirc & Skaleric (2007)   \[[@B57]\]   Surgery                 RCT split   5         25         MWF+Er:YAG   MWF                             GI, PI, BOP, PD, REC, CAL
  Isidor & Karring (1986)     \[[@B39]\]   Surgical/non-surgical   CCT         5         16         MWF          SRP       RBF                   PI, GI, PD, CAL
  Kaldahl et al. (1996)       \[[@B43]\]   Surgical/non-surgical   RCT         7         51         FOS          MWF       SRP, CSC              PI, PD, CAL, BOP, REC, SUP, TL
  Kaldahl et al. (1996)       \[[@B31]\]   Surgical/non-surgical   RCT         7         51         FOS          MWF       SRP, CSC              PD, CAL
  Lindhe et al. (1984)        \[[@B42]\]   Surgical/non-surgical   RCT split   5         11         MWF          SRP                             CAL, PD
  Pihlstrom et al. (1983)     \[[@B32]\]   Surgical/non-surgical   RCT split   6.5       10         MWF          SRP                             CAL, PD
  Pihlstrom et al. (1984)     \[[@B33]\]   Surgical/non-surgical   RCT split   6.5       10         MWF          SRP                             CAL, PD, TL
  Preus et al. (2017)         \[[@B36]\]   Non-surgical            RCT         5         161        SRP+MET      SRP+PL    FMDIS+PL, FMDIS+MET   PI, BOP, PD, CAL
  Ramberg et al. (2001)       \[[@B37]\]   Non-surgical            CCT         5         115        SRP+TTR      SRP                             PI, BOP, CAL, PD, RX
  Ramfjord et al. (1975)      \[[@B56]\]   Surgical/non-surgical   RCT split   5         79         MWF          CUR       PE                    CAL, PD
  Knowles et al. (1979)       \[[@B30]\]   Surgical/non-surgical   RCT split   8         43         MWF          CUR       PE                    CAL, PD
  Ramfjord et al. (1987)      \[[@B41]\]   Surgical/non-surgical   RCT split   5         72         MWF          SRP       PE, CUR               CAL, PD, TL
  Renvert et al. (1996)       \[[@B55]\]   Surgical/non-surgical   CS          5         12         MWF          SRP                             CAL, PD, Micro
  Rosling et al. (2001)       \[[@B34]\]   Non-surgical            PCS         12        334                     SRP                             CAL, PD, PI, TL, RX
  Serino et al. (2001)        \[[@B40]\]   Surgical/non-surgical   RCT         13        64         MWF          SRP                             CAL, BOP, PD, RX

BOP: bleeding on probing, CAL: clinical attachment level, CCT: Controlled clinical trial, CO2L, CO~2~ laser, CS: case series, CSC: coronal scaling, CUR: curettage, FU: follow-up, FOS: flap osseous surgery, FMDIS: full mouth disinfection, GI: gingival index, MET: metronidazole, Micro: microbiology, MWF: modified Widman flap, PCS: prospective cohort study, PD: probing depth, PE: pocket elimination, PL: placebo, PI: plaque index, RBF: reverse bevel flap, RCT: randomized controlled trial, REC: recession, RX: radiograph, SRP: scaling and root planing, SUP: suppuration, TL: tooth loss, TTR: tetracycline.

SPT
---

SPT was reported in all studies. The reported recall program varied significantly, although most investigations included an intensive period of recall after treatment that lasted 6--24 months and was followed by a regular recall program with appointments every 3, 4, or 6 months ([Table 3](#T3){ref-type="table"}).

###### Periodontal disease progression as reported in the different studies

![](jpis-49-60-i003)

  Publication                                                                                       SPT                                                                                                                                                                               PD                                                                                                 CAL                                                                             Frequency distributions
  ------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Axelsson & Lindhe (1981) \[[@B38]\]                                                               One-third patients received maintenance by dentist (NRG). Two-third university program with 1 appointment per 2 mon the first 2 yr and then 1 appointment per 3 mon after (RG).   NRG: 1.8±0.24 (BS) to 2.9±0.51 (6 yr).                                                             NRG: 3.7±1.11 (BS) to 5.5±1.11 (6 yr).                                          PD: 18% increase of 4--6 mm at 6 yr in NRG.
  RG: 1.9±0.32 (BS) to 1.6±0.35 (6 yr).                                                             RG: 4.2±0.90 (BS) to 4.0±0.93 (6 yr).                                                                                                                                             Among sites with CAL loss: NRG; 44% ≤1 mm, 55% 2--5 mm, and 1% ≥6 mm. RG; 99% ≤1 mm, 1% 2--5 mm.                                                                                   
  Crespi et al. (2011) \[[@B35]\]                                                                   Patients were recalled every 2 wk for 3 mon and twice a yr thereafter.                                                                                                            Change BS-15 yr                                                                                    Change BS-15 yr                                                                 NR
  i\) 1--4 mm; MWF: 0.61 mm, LT: 0.35 mm.                                                           i\) 1--4 mm; MWF: −0.39 mm, LT: −0.38 mm.                                                                                                                                                                                                                                                                                                                            
  ii\) 5--6 mm; MWF: 0.03 mm, LT: 0.3 mm.                                                           ii\) 5--6 mm; MWF: −0.24 mm, LT: 0.3 mm.                                                                                                                                                                                                                                                                                                                             
  iii\) ≥7 mm; MWF: 0.95 mm, LT: 0.4 mm.                                                            iii\) ≥7 mm; MWF: −0.94 mm, LT: 0.37 mm.                                                                                                                                                                                                                                                                                                                             
  Gaspirc & Skaleric (2007) \[[@B57]\]                                                              SPT 1/mon for 3 mon and at mon 6 post-surgery, then 1/6 mon during the remainder of the study.                                                                                    MW: 2.92±0.7 mm (BS) to 2.91±0.55 mm (5 yr)                                                        MW: 3.81±1.06 mm (BS) to 4.05±0.85 mm (5 yr)                                    NR
  LT: 2.82±0.70 mm (BS) to 2.84±0.43 mm (5 yr)                                                      LT: 3.66±0.81 mm (BS) to 3.97±0.89 mm (5 yr)                                                                                                                                                                                                                                                                                                                         
  Isidor & Karring (1986) \[[@B39]\]                                                                First yr 1 professional cleaning every 2 wk.                                                                                                                                      MWF: 2.3 mm (BS), 3.1 mm (5 yr).                                                                   Change BS-5 yr                                                                  Eighteen surfaces (7.1%) in MWF and 7 surfaces in SRP (2.9%) showed ≥2 mm loss of CAL. Overall 48 surfaces (4.9%) showed an attachment loss of ≥2 mm after 5 yr.
  During 2nd yr 1/3 mon from then every 6 mon.                                                      SRP: 3.1 mm (BS), 3.2 mm (5 yr).                                                                                                                                                  MWF: −0.2mm, SRP: 0.4 mm                                                                                                                                                           
  Kaldahl et al. (1996) \[[@B43]\]                                                                  1/3 mon after surgery, plaque control, OHI, CSC, SRP if necessary.                                                                                                                Change BS-7 yr                                                                                     Change BS-7 yr                                                                  Tooth loss: 19 originally treated with CSC, 21 with SRP, 20 with MWF, and 5 teeth treated with FOS were extracted due to probing depth progressing past the apex.
  i\) 1--4 mm; SRP: 0 mm, MWF: 0.2 mm, FOS: 0.5 mm.                                                 i\) 1--4 mm; SRP: −0.3 mm, MWF: −0.5 mm, FOS: 0.1 mm.                                                                                                                                                                                                                                                                                                                
  ii\) 5--6 mm; SRP: 0.2 mm, MWF: 0.2 mm, FOS: 0.6 mm.                                              ii\) 5--6 mm; SRP: 0 mm, MWF: −0.1 mm, FOS: 0.1 mm.                                                                                                                                                                                                                                                                                                                  
  iii\) ≥7 mm; SRP: −0.4 mm, MWF: 0.1 mm, FOS: 0.5 mm.                                              iii\) ≥7 mm; SRP: 0.3 mm, MWF: 0.1 mm, FOS: 0.1 mm.                                                                                                                                                                                                                                                                                                                  
  Kaldahl et al. (1996) \[[@B31]\]                                                                  One-third mon after surgery, plaque control, OHI, CSC, SRP if necessary.                                                                                                          Reported in Kaldahl et al. (1996) \[[@B43]\]                                                       Reported in Kaldahl et al. (1996) \[[@B43]\]                                    Breakdown defined ≥3 mm CAL loss. 35 patients had ≤0.99% sites with breakdown, 34 patients 1%--3% sites, 8 patients 3%--6% sites. Patients having an incidence of a \>3.00% were smokers at BS.
  Lindhe et al. (1984) \[[@B42]\]                                                                   For first 6 months professional tooth cleaning once/2 wk, next 18 mon once/3 mon. After this SRP was avoided and SPT were every 4--6 mon.                                         MWF: ±1 mm, 76% sites; +2 mm, 14%; −2 mm, 7%.                                                      MWF: ±1 mm, 84% sites; −2 mm, 9%; −2 mm, 5%.                                    CAL gains of ≥2 mm in 2% sites. CAL loss ≥2 mm in 10%--12% of sites. Patients with poor oral hygiene had 20% of sites loss ≥2 mm while in good oral hygiene only 2%--3% sites.
  SRP: ±1 mm, 84% sites; −2 mm, 9%; +2 mm, 5%.                                                      SRP: ±1 mm, 85% sites; −2 mm, 7%; +2 mm, 7%.                                                                                                                                                                                                                                                                                                                         
  Pihlstrom et al. (1983) \[[@B32]\]                                                                Three to 4 times per year. OHI, CSC and SRP for 1 hr.                                                                                                                             MWF: 1--3 mm, 0.3mm; 4--6 mm, 0.4 mm; \>7 mm, 0.7 mm.                                              MWF: 1--3 mm, 0.1 mm; 4--6 mm, 0.2 mm; \>7 mm, −0.2 mm.                         NR
  SRP: 1--3 mm, 0.2 mm; 4--6 mm, 0.05 mm; \>7 mm, 0.2 mm.                                           SRP: 1--3 mm, 0.1 mm; 4--6 mm, 0.3 mm; \>7 mm, 0.3 mm.                                                                                                                                                                                                                                                                                                               
  Pihlstrom et al. (1984) \[[@B33]\]                                                                Three to 4 times per yr. OHI, CSC and SRP for 1 hr.                                                                                                                               Change BS-6.5 yr                                                                                   Change BS-6.5 yr                                                                NR
  i\) 4--6 mm: MWF: Mol: 0.7, non-Mol: −0.31. SRP: Mol: −0.21, non-Mol: 0.3.                        4--6 mm: MWF: Mol: −0.06, non-Mol: 0.41. SRP: Mol: 0.21, non-Mol: 0.29.                                                                                                                                                                                                                                                                                              
  ii\) \>7 mm: MWF: Mol: 0.48, non-Mol: −0.3. SRP: Mol: 0.74, non-Mol: −0.45                        \>7 mm: MWF: Mol: −0.38, non-Mol: −0.3. SRP: Mol: −0.13, non-Mol: 0.5                                                                                                                                                                                                                                                                                                
  Preus et al. (2017) \[[@B36]\]                                                                    SPT at 3, 6, and 12 mon after therapy, and every 6 mon after that. SPT consisted of CSC and SRP and sites that required it.                                                       Change BS-5 yr                                                                                     Change BS-5 yr                                                                  Trend for increase in the number of teeth with PPD ≥5 mm noted, occurrence of PPD ≥5 mm remained stable.
  FMDIS-MET: 0.2 mm, FDIS: 0.15 mm, SRP+MET: 0.17 mm, SRP: 0.21 mm.                                 FMDIS-MET: −0.53 mm, FDIS: −0.47 mm, SRP+MET: −0.74 mm, SRP: −0.44 mm.                                                                                                            TL: None, 45%; 1 TL, 24%; 2 TL, 14%; 3 TL, 9%; ≥4 TL, 8%.                                                                                                                          
  Ramberg et al. (2001) \[[@B37]\]                                                                  SPT 3--4 times per yr.                                                                                                                                                            Change BS-13 yr                                                                                    Change BS-13Y: TTR: −1mm, SRP: −1.1mm                                           PD; BS
  TTR(test): 0.4 mm, SRP(control): 0.3mm                                                            ≤3 mm: test, 43%; control, 49%; 4--6 mm: test, 42%; control, 39%; ≥7 mm: test, 15%; control, 12%.                                                                                                                                                                                                                                                                    
  13 yr                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  ≤3 mm: test, 57%; control, 61%; 4--6 mm: test, 35%; control, 32%; ≥7 mm: test, 8%; control, 7%.                                                                                                                                                                                                                                                                                                                                                                        
  Ramfjord et al. (1975) \[[@B56]\]                                                                 SPT every 3 mon.                                                                                                                                                                  Change in interproximal mean PPD: CUR, −0.3mm; MWF, −0.4 mm; PEL, −0.58 mm.                        Change in mean interproximal CAL: CUR, 0.38 mm; MWF, −0.02 mm; PEL, −0.06 mm.   NR
  Knowles et al. (1979) \[[@B30]\]                                                                  SPT every 3 mon.                                                                                                                                                                  Overall change in PD: 1--3 mm, −0.35 mm; 4--6 mm, −0.3 mm; ≥7 mm, −0.2 mm.                         Overall change in CAL: 1--3 mm, −0.3 mm; 4--6 mm, 0.25 mm; ≥7 mm, −0.4 mm.      NR
  Ramfjord et al. (1987) \[[@B41]\]                                                                 Once per wk for 4 wk post-surgically, and later once 1/3 mon for 5 yr.                                                                                                            BS-5 yr                                                                                            Change BS-5 yr in mm                                                            \% Sites CAL loss ≥2 mm
  i\) 1--3 mm; PEL: 0.43, CUR: 0.1, MWF: 0.17, SRP: 0.03.                                           i\) 1--3 mm; PEL: −0.53, CUR: −0.64, MWF: −0.56, SRP: 0.62.                                                                                                                       i\) 1--3 mm, PEL: 38.1, CUR: 33.6, MWF: 35.4, SRP: 30.3.                                                                                                                           
  ii\) 4--6 mm; PEL: −0.52, CUR: −0.65, MWF: 0.39, SRP: 0.18.                                       ii\) 4--6 mm; PEL: −0.49, CUR: −0.42, MWF: −0.43, SRP: −0.57.                                                                                                                     ii\) 4--6 mm; PEL: 29.3, CUR: 22.6, MWF: 27.9, SRP: 21.1.                                                                                                                          
  iii\) ≥7 mm; PEL: −0.64, CUR: 1.29, MWF: 0.28, SRP: −0.07.                                        iii\) ≥7 mm; PEL: 0.26, CUR: 0.4, MWF: 0.5, SRP: 0.4.                                                                                                                             iii\) ≥7 mm; PEL: 10.8, CUR: 10.9, MWF: 8.1, SRP: 14.8.                                                                                                                            
  Renvert et al. (1996) \[[@B55]\]                                                                  One-third mon for 3 yr and thereafter every 6 mon. Plaque scores, OHI, CSC, no SRP.                                                                                               PD change BS-5 yr: 1.4 mm                                                                          CAL change BS-5 yr: −0.5 mm                                                     NR
  Rosling et al. (2001) \[[@B34]\]                                                                  Three to 4 times per year, according to individual needs. OHI, BOP, PD.                                                                                                           \% of molar sites exhibiting an increase in PD ≥2 mm                                               CAL change: NG: 0.45 mm, HSG: 0.8 mm                                            NG 10% of subjects had 8 teeth exhibiting ≥2 mm CAL loss. 70% of HSG subjects had \>8 teeth with ≥2 mm CAL change.
  i\) 0--3 mm; NG: 4.6%, HSG: 34.3%.                                                                                                                                                                                                                                                                                                                                                                                                                                     
  ii\) 4--5 mm; NG: 2.4%, HSG: 25.6%.                                                                                                                                                                                                                                                                                                                                                                                                                                    
  iii\) ≥6 mm; NG: 16.1%, HSG: 18.1%.                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Serino et al. (2001) \[[@B40]\]                                                                   SPT 4 times per year. Plaque control. Additional SRP at sites ≥5 mm.                                                                                                              PD change BS-13 yr                                                                                 Mean annual CAL loss                                                            Annual % of sites ≥2 mm CAL loss stratified by PD CAL loss in PD ≥6 mm
  SRP: 0.6 mm, MWF: 0.6 mm.                                                                         i\) SRP: 0.08 mm (1--3 yr), 0.11 mm (3--5 yr), and 0.07 mm (5--13 yr).                                                                                                            i\) SRP: 7.5% (1--3 yr), 7.8% (3--5 yr), 2.9% (5--13 yr).                                                                                                                          
  ii\) MWF: 0.11 mm (1--3 yr), 0.07mm (3--5 yr), 0.07mm (5--13 yr).                                 ii\) MWF: 5% (1--3 yr), 4% (3--5 yr), 2.3% (5--13 yr).                                                                                                                                                                                                                                                                                                               

Baseline was considered to be the first examination after the completion of active therapy.

Aa: *Actinobacillus actinomycetemcomitans*, BOP: bleeding on probing, BS: baseline, CAL: clinical attachment level, CSC: coronal scaling, CUR: curettage, FMDIS: full mouth disinfection, FOS: flap osseous surgery, FU: follow-up, HSG: high susceptibility group, LT: laser therapy, MET: metronidazole, Micro: microbiology, Mol: molar, MWF: modified Widman flap, NG: normal group, NR: not reported, NRG: non-recall group, OHI: oral hygiene instructions, PD: probing depth, PEL: pocket elimination surgery, PG: *Porphyromonas gingivalis*, RG: recall group, SPT: supportive periodontal therapy, SRP: scaling and root planing, TL: tooth loss, TTR: tetracycline.

Primary outcome
---------------

The primary outcome was assessed by CAL measurements or by the frequency distribution of sites with attachment loss at the most recent follow-up appointment. The majority of the studies reported CAL values according to the different treatment modalities, although some studies stratified CAL values according to other factors, such as the type of recall \[[@B38]\], smoking \[[@B31]\] and patients\' susceptibility \[[@B34]\].

Of the studies that compared CAL at the most recent follow-up to CAL after active periodontal therapy (surgical or non-surgical), 10 reported a mean CAL loss of ≤0.5 mm, 3 reported a mean CAL loss from 0.5 to 1 mm, and 4 reported a mean CAL loss of \>1 mm.

Seven publications provided information on the frequency distribution of sites with attachment loss \[[@B24][@B31][@B34][@B38][@B39][@B40][@B41]\]. Among them, only 1 reported the number of patients who lost attachment, in addition to the site analysis \[[@B31]\]. Five studies reported the frequency of sites that lost ≥2 mm, while 1 publication used a cut-off value of 3 mm \[[@B31]\] and 1 publication reported the percentage of sites with ≤1 mm, 2-5 mm, and ≥6 mm of CAL loss \[[@B38]\]. The percentage of sites showing ≥2 mm of CAL loss varied from 3% \[[@B39]\] to 20% \[[@B34][@B42]\]. Several factors were identified as influencing CAL loss; in patients with poor oral hygiene (defined as a low frequency of sites with plaque free surfaces), 20% of sites had ≥2 mm of CAL loss \[[@B42]\] and smokers presented a disproportionately high percentage of sites with ≥3 mm of CAL loss \[[@B31]\]. Two of the 7 publications allowed for re-instrumentation at sites where disease progression was detected, and therefore reported the yearly incidence of breakdown sites \[[@B31][@B40]\].

Four studies stratified CAL loss based on baseline probing depth (PD), with no apparent differences with regard to disease progression between the different levels of PD \[[@B31][@B40][@B41][@B42]\] ([Table 3](#T3){ref-type="table"}).

Most investigations found few long-term differences in the mean change of CAL between sites treated by SRP and MWF. One publication, however, found that SRP-treated subjects exhibited more signs of advanced disease progression in the 1--3 years period following active therapy than MWF-treated subjects \[[@B40]\]. Another publication found that MWF led to a greater sustained gain in CAL than curettage in sites with ≥7 mm of CAL \[[@B30]\], while another publication demonstrated that SRP led to a greater long-term gain of CAL than MWF in sites with 4--6 mm depths \[[@B32]\]. Regarding the utilization of FOS, the initial changes that occurred after surgery led to a more pronounced CAL loss, since greater recession occurred. Nonetheless, no evident differences were observed when analyzing CAL changes after treatment between sites that underwent SRP or MWF compared to FOS \[[@B43]\].

The utilization of systemic antibiotics as adjuncts to SRP, as reported in 2 publications, did not appear to have an additional benefit in terms of CAL changes after 5 years of therapy \[[@B37][@B44]\].

Finally, 4 publications evaluated CAL changes based on proximal or interproximal surfaces \[[@B24][@B30][@B38][@B40]\] and 3 studies stratified molar versus non-molar sites \[[@B33][@B34][@B36]\], reaching an overall agreement that interproximal sites and molar sites presented higher amount of CAL loss.

Secondary outcomes
------------------

PD was reported in the studies as described for CAL. Nine studies reported the mean PD values at baseline (after completion of active periodontal therapy) and the most recent follow-up or mean PD changes. Among them, 5 studies reported a mean PD change of ≤0.5 mm, 2 studies reported changes between 0.5 and 1 mm and two studies reported changes \>1 mm. Five studies reported mean PD values stratified by the initial PD, and found no apparent influence of deeper pockets at baseline (\>7 mm) on changes in PD at the final evaluation. Two studies, however, reported higher PD increases at the final evaluation in initial deep pockets \[[@B35][@B41]\]. One publication reported a higher PD increase at molar sites than at non-molar sites \[[@B33]\]. Frequency distributions were used in 4 studies that reported the number of sites in each category of PD changes. Approximately 80% of the sites were found to have changes within 1 mm at the final evaluation \[[@B42]\]. Patients considered to have high susceptibility were also found to have more sites with a PD change ≥2 mm \[[@B34]\]. Similarly, patients who showed erratic compliance presented a 20% higher prevalence of pockets ≥4 mm after 6 years than patients who regularly attended SPT \[[@B38]\].

Regarding the effect of the intervention in PD changes, MWF appeared to produce a greater mean PD reduction than SRP, but the differences dissipated as time progressed. One publication, however, observed that MWF was more effective than SRP in reducing the overall mean PD and in eliminating deep pockets \[[@B40]\]. One publication reported a greater PD reduction in deeper sites treated by FOS \[[@B43]\], while 2 studies found no long-term difference on PD levels for FOS when compared to other therapies \[[@B30][@B41]\].

The utilization of metronidazole or tetracycline as adjuncts to SRP did not appear to have an additional benefit in terms of PD changes after 5 years of therapy \[[@B36][@B37]\].

Furthermore, 4 studies reported tooth loss. The reasons for tooth loss included endodontic reasons, non-restorability, and periodontal disease progression. One publication reported that fewer than 1% of the extracted teeth were extracted for periodontal reasons \[[@B41]\], while another publication reported that in patients considered to have high susceptibility to periodontal disease, most tooth loss was associated with progressive periodontal disease, whereas in the non-susceptible group, endodontic reasons and caries were the most common reasons for tooth loss \[[@B34]\]. Finally, 3 studies reported radiographic outcomes, and 1 publication reported microbiological outcomes 5 years after treatment.

DISCUSSION
==========

The present systematic review found that the results achieved after surgical or non-surgical therapy were stable over a period of 5 years, as observed through the CAL measurements. Disease progression was circumscribed to limited sites and individuals. Progression was more frequent at proximal sites and molars, and in individuals with poor oral hygiene, those who showed poor compliance with recall, and smokers. The analysis of the influence of the treatment approach on the progression of periodontal disease yielded inconclusive results on the superiority of a particular technique or approach.

It must be taken into consideration that mean CAL values were reported after completion of active periodontal therapy and compared to those that occurred at the most recent follow-up evaluation. Relying on mean values for making assessments of long-term treatment outcomes runs the risk of the numerous sites that remain stable overshadowing the relatively small percentage of sites that lose attachment. For this reason, the validity of using individual mean values to describe alterations of periodontal conditions during SPT following active periodontal therapy has been questioned \[[@B24]\].

It is precisely for the above-mentioned reasons that the authors refrained from performing a meta-analysis of the gathered data, and instead focused on reporting the frequency distribution of sites losing attachment and the yearly incidence of breakdown sites. A meta-analysis on this secondary outcome could not be performed due to heterogeneity in the reporting of frequency distributions of sites that lost attachment and because the majority of the publications reported percentages and not on the overall number of sites that remained stable or lost attachment. Whenever possible, the CAL data were reported stratified by pocket depth. This was done because shallow crevices are weighted heavily when computing overall patient means for CAL and PD, potentially masking what occurs at deeper sites.

Overall, sites with greater initial PD showed greater initial PD reduction and CAL gain, while at the most recent follow-up evaluation, shallow sites tended to lose attachment and deeper sites tended to show reduced CAL values. Although these findings are in agreement with recent longitudinal studies that have evaluated disease progression \[[@B14]\], it must be taken into consideration that tooth loss and reasons for tooth extraction were scarcely reported, meaning that disease progression, ultimately leading to tooth extraction, may have occurred at deep sites and gone unnoticed.

When evaluating the factors associated with disease progression through the incidence of sites losing attachment it became evident that oral hygiene, attendance to recall, and smoking were the most relevant factors. In patients with poor oral hygiene, 20% of sites had ≥2 mm of CAL loss, while in those with good oral hygiene, only 2%-3% of sites lost ≥2 mm \[[@B42]\]. Among the sites that lost CAL in patients who regularly attended SPT, 99% of the sites lost ≤1 mm of CAL, while in erratic compliers, 44% of the sites lost ≤1 mm and 55% lost 2--5 mm \[[@B38]\]. Similarly, when analyzing the patients that had an incidence of \>3% of sites with ≥3 mm of CAL loss, all patients were found to have a smoking habit at baseline \[[@B31]\]. In addition, other factors such as the susceptibility to periodontal disease appeared to play a role; while in regular patients, 10% of subjects had 8 teeth exhibiting ≥2 mm of CAL loss, 70% of those considered highly susceptible had \>8 teeth with ≥2 mm of CAL \[[@B34]\]. These findings are in agreement with those reported by Fardal and colleagues \[[@B45]\], who analyzed the re-treatment profiles of patients during long-term SPT and concluded that the predictors of surgical re-treatment were poor compliance with SPT, a family history of periodontal disease, and poor prognosis at baseline. Equivalent results were found in a large population reporting an association between irregular compliance and recurrence rates of periodontitis \[[@B46]\], and smoking has been found to show an odds ratio of 10.7 for having ≥ 1 site with bone loss of ≥2 mm \[[@B47]\]. These findings highlight the importance of closely supervising patients who have been treated for periodontal disease, continuously monitoring oral hygiene, and emphasizing smoking cessation programs.

Furthermore, patients with a history of periodontal disease who have shown susceptibility to the disease process appear to be more likely to have new sites with CAL loss. Some reports have concluded that subjects under maintenance after periodontal therapy displayed more rapid attachment loss than periodontally healthy subjects, which indicates that, similarly to what has been found in untreated patients, healthy and diseased subjects may have different patterns of disease progression \[[@B48][@B49]\].

Although the objective of this systematic review was not to explore the effect of interventions, the present investigation found heterogeneous results with regard to the influence of the type of therapy provided at baseline in the development of further attachment loss. These findings are reasonable, given that the tested interventions were randomized per quadrant and pockets of different depths were included in each therapy, with no possibility of applying more interventional approaches to deeper sites and less invasive therapies for shallower sites in the same quadrant. In a recently published systematic review, it was concluded that surgical therapy led to significantly more CAL loss than non-surgical therapy in sites with shallow PD. In sites with moderate PD, MWF yielded significantly more PD reduction than SRP, and there was significantly less CAL gain with surgical therapy. Finally, in sites with deep PD, FOS led to significantly greater PD reduction than SRP \[[@B20]\].

The conclusions of the present systematic review must be interpreted with caution, since it has been shown that factors assessed independently may not be valuable for predicting the risk of future attachment loss. Instead, the combination of factors in a multifactorial model may be useful for identifying individuals at risk for disease progression \[[@B26]\]. A number of multifactorial models for risk assessment have been developed, suggesting the need for a continuous multilevel risk assessment at the patient, tooth, and tooth site level to improve predictive power \[[@B50][@B51][@B52][@B53][@B54]\].

Nevertheless, the present systematic review highlights the importance of well-established classic periodontal concepts that are supported by the available evidence and that underscore the benefits of preventive measures such as attendance to SPT, reinforcement of plaque control, and promotion of smoking cessation programs to maintain the results achieved after surgical or non-surgical periodontal therapy.

CONCLUSIONS
===========

The results obtained after surgical or non-surgical therapy in terms of CAL were stable over a period of 5 years. Disease progression was limited to a small number of patients, was more frequent at proximal sites and molar sites, and was associated with poor oral hygiene, poor compliance with recall, and smoking. The results of the present investigation highlight the importance of closely supervising patients who have been treated for periodontal disease, continuously monitoring oral hygiene, and emphasizing smoking cessation programs.
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